Bandyopadhyay; Rebanta

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bandyopadhyay; Rebanta.The latest application filed is for "stable pharmaceutical formulations of peptide and protein drugs".

Company Profile

0.7.17

Bandyopadhyay; Rebanta - Webster NY
Bandyopadhyay; Rebanta - Geneva NY
Bandyopadhyay; Rebanta - Portage MI
Bandyopadhyay; Rebanta - Hyderabad IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable Pharmaceutical Formulations Of Peptide And Protein Drugs App 20220184173 - Bandyopadhyay; Rebanta ; et al.	2022-06-16
Concentrated Acetaminophen Solution App 20160144033 - Bandyopadhyay; Rebanta ; et al.	2016-05-26
Parenteral Formulation For Epothilone Analogs App 20150218179 - Bandyopadhyay; Rebanta ; et al.	2015-08-06
Water-miscible Stable Solution Composition For Pharmaceutically Active Ingredients That Are Poorly Soluble In Water And Susceptible To Chemical Degradation App 20150141518 - Bandyopadhyay; Rebanta ; et al.	2015-05-21
Method To Improve The Safety Of Handling Of High Potency Drugs In Solid Dosage Forms Without Changing Their Efficacy App 20150037407 - Bandyopadhyay; Rebanta ; et al.	2015-02-05
Parenteral Formulation For Epothilone Analogs App 20140107169 - Bandyopadhyay; Rebanta ; et al.	2014-04-17
Parenteral formulation for epothilone analogs Grant 8,632,788 - Bandyopadhyay , et al. January 21, 2	2014-01-21
Method To Improve The Safety Of Handling Of High Potency Drugs In Solid Dosage Forms Without Changing Their Efficacy App 20130251804 - Bandyopadhyay; Rebanta ; et al.	2013-09-26
Parenteral Formulation For Epothilone Analogs App 20090069393 - Bandyopadhyay; Rebanta ; et al.	2009-03-12
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones Grant RE40,387 - Bandyopadhyay , et al. June 17, 2	2008-06-17
Parenteral formulation for epothilone analogs Grant 7,022,330 - Bandyopadhyay , et al. April 4, 2	2006-04-04
Parenteral formulation for epothilone analogs App 20060013836 - Bandyopadhyay; Rebanta ; et al.	2006-01-19
Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders App 20040058926 - Bandyopadhyay, Rebanta ; et al.	2004-03-25
Methods of administering epothilone analogs for the treatment of cancer Grant 6,670,384 - Bandyopadhyay , et al. December 30, 2	2003-12-30
Controlled release dosage form having improved drug release properties App 20030152624 - Aldrich, Dale S. ; et al.	2003-08-14
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones Grant 6,576,651 - Bandyopadhyay , et al. June 10, 2	2003-06-10
Topical antibiotic composition for treatment of eye infection Grant 6,551,584 - Bandyopadhyay , et al. April 22, 2	2003-04-22
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones App 20020177615 - Bandyopadhyay, Rebanta ; et al.	2002-11-28
Methods of administering epothilone analogs for the treatment of cancer App 20020169190 - Bandyopadhyay, Rebanta ; et al.	2002-11-14
Parenteral formulation for epothilone analogs App 20020143038 - Bandyopadhyay, Rebanta ; et al.	2002-10-03
Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders App 20020128267 - Bandyopadhyay, Rebanta ; et al.	2002-09-12
Topical antibiotic composition for treatment of eye infection App 20020107238 - Bandyopadhyay, Rebanta ; et al.	2002-08-08
Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug App 20020035264 - Kararli, Tugrul T. ; et al.	2002-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.